Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart Project

European Journal of Clinical Investigation

Volumn 33, Issue 8, 2003, Pages 686-692

  Tavridou, A ^a,f   Unwin, N ^b,d   Bhopal, R ^c,e   Laker, M F ^b,d  

^a ELPEN Pharmaceuticals   (Greece)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ELPEN Pharmaceutical Co Inc   (Greece)

Author keywords

Apolipoprotein(a); Cross sectional study; European; Genotype; Lipoprotein(a); South Asian

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOUTH ASIA; STATISTICAL ANALYSIS;

ADULT; AGED; APOLIPOPROTEINS A; BANGLADESH; BLOTTING, SOUTHERN; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; GENOTYPE; HOMEOSTASIS; HUMANS; INDIA; INSULIN RESISTANCE; LIPOPROTEIN(A); MALE; MIDDLE AGED; PAKISTAN; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0042666919     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01201.x     Document Type: Article

References (36)

1. Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. Lipoprotein(a) as a risk factor for ischaemic heart disease: metaanalysis of prospective studies. Clin Chem 1998;44:2301-6.
2. McLean JW, Tomlinson JE, Kuang W, Eaton DL, Chen EY, Fless GM et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;300:132-7.
3. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987;80:458-65.
4. Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Császár A et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991;86:607-14.
5. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992;90:52-60.
6. Akita H, Matsubara M, Shibuya H, Fuda H, Chiba H. Effect of ageing on plasma lipoprotein(a) levels. Ann Clin Biochem 2002;39:237-40.
7. Farrer M, Game FL, Albers CJ, Neil HA, Winocour PH, Laker MF et al. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb Vasc Biol 1994;14:1272-83.
8. Kinlay S, Dobson AJ, Heller RF, McElduff P, Alexander H, Dickeson J. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women. J Am Coll Cardiol 1996;28:870-5.
9. Slunga L, Asplund K, Johnson O, Dahlen GH. Lipoprotein(a) in a randomly selected 25-64 year old population: the Northern Sweden Monica Study. J Clin Epidemiol 1993;46:617-24.
10. Nakata H, Horita K, Eto M. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications. Metabolism 1993;42:1323-6.
11. Paassilta M, Kervinen K, Rantala AO, Savolainen MJ, Lilja M, Reunanen A et al. Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: Population based study. Br Med J 1998;316:594-5.
12. Siekmeier R, Marz W, Kronenberger H, Seiffert UB, Gross W. Effects of cigarette smoking on plasma lipids, apolipoproteins, and lipoprotein(a) in healthy subjects [letter]. Clin Chem 1994;40:1350-1.
13. Djurovic S, Berg K. Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease. Clin Genet 1997;52:281-92.
14. Kraft HG, Lingenhel A, Köchl S, Hoppichler F, Kronenberg F, Abe A et al. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996;16:713-9.
15. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1989;42:597-609.
16. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. Br Med J 1999;319:215-20.
17. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
18. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995;345:405-9.
19. Wilson PW, Paffenbarger RS Jr, Morris JN, Havlik RJ. Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. Am Heart J 1986;111:1177-92.
20. WHO. Study Group on Diabetes. Geneva, 1985.
21. Gaw A, Gourlay CWD, Brown EA, Bell MA. Evaluation of a new automated latex agglutination assay for lipoprotein(a): Comparison with a manual ELISA. Clin Chim Acta 1997;261:175-83.
22. Tavridou A, Laker MF. Field inversion gel electrophoresis for apolipoprotein(a) genotyping. Anal Biochem 1999;272:282-5.
23. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991;87:2153-61.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment, insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
25. Petrie J, O'Brien E, Littler W et al. Recommendations on Blood Pressure Measurement. London: BMJ Publications; 1990.
26. Boerwinkle E, Menzel HJ, Kraft HG, Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp (a) glycoprotein phenotypes to normal lipid variation. Hum Genet 1989;82:73-8.
27. Kraft HG, Lingenhel A, Pang RWC, Delport R, Trommsdorff M, Vermaak H et al. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: The distribution of null alleles is non-random. Eur J Hum Genet 1996;4:74-87.
28. Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism 1998;47:182-4.
29. Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991;37:1950-4.
30. Duell PB, Hagemenas F, Connor WE. The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care 1994;17:1135-40.
31. Sidhu M, Crook D, Godsland IF, Walton C, Wynn V, Oliver MF. Inverse relationship between serum Lp(a) levels and first-phase insulin secretion. Diabetes 1992;41:1341-5.
32. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Commun H 1997;51:394-9.
33. Cohen JC, Chiesa G, Hobbs HH. Sequence polymorphisms in the apolipoprotein(a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest 1993;91:1630-6.
34. Rainwater DL. Genetic basis for multimodal relationship between apolipoprotein(a) size and lipoprotein(a) concentration in Mexican-Americans. Atherosclerosis 1995;115:165-71.
35. Mooser V, Mancini FP, Bopp S, Petho-Schramm A, Guerra R, Boerwinkle E et al. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet 1995;4:173-81.
36. Puckey LH, Lawn RM, Knight BL. Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration. Hum Mol Genet 1997;6:1099-107.